tiprankstipranks
Trending News
More News >
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market

4D Molecular Therapeutics (FDMT) Cash flow

Compare
515 Followers

4D Molecular Therapeutics Cash Flow

FDMT's free cash flow for Q4 2025 was $27.92M. For the 2025 fiscal year, FDMT's free cash flow was decreased by $29.29M and operating cash flow was $28.55M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -109.08M$ -134.59M$ -75.79M$ -86.69M$ -69.13M
Investing Cash Flow
$ -92.97M$ -302.44M$ 115.72M$ -17.05M$ -172.68M
Financing Cash Flow
$ 112.96M$ 337.25M$ 156.83M$ 3.08M$ 118.09M
End Cash Position
$ 60.24M$ 149.34M$ 249.11M$ 52.35M$ 153.00M
Free Cash Flow
$ -109.08M$ -138.37M$ -78.56M$ -98.22M$ -78.24M
Currency in USD

4D Molecular Therapeutics Cash Flow